163 related articles for article (PubMed ID: 27503929)
1. Chromatin-Remodeling Complex SWI/SNF Controls Multidrug Resistance by Transcriptionally Regulating the Drug Efflux Pump ABCB1.
Dubey R; Lebensohn AM; Bahrami-Nejad Z; Marceau C; Champion M; Gevaert O; Sikic BI; Carette JE; Rohatgi R
Cancer Res; 2016 Oct; 76(19):5810-5821. PubMed ID: 27503929
[TBL] [Abstract][Full Text] [Related]
2. The SWI/SNF complex and cancer.
Reisman D; Glaros S; Thompson EA
Oncogene; 2009 Apr; 28(14):1653-68. PubMed ID: 19234488
[TBL] [Abstract][Full Text] [Related]
3. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
Raab JR; Runge JS; Spear CC; Magnuson T
Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
[TBL] [Abstract][Full Text] [Related]
4. SWI/SNF nucleosome remodellers and cancer.
Wilson BG; Roberts CW
Nat Rev Cancer; 2011 Jun; 11(7):481-92. PubMed ID: 21654818
[TBL] [Abstract][Full Text] [Related]
5. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
[TBL] [Abstract][Full Text] [Related]
6. BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors.
Wang X; Wang S; Troisi EC; Howard TP; Haswell JR; Wolf BK; Hawk WH; Ramos P; Oberlick EM; Tzvetkov EP; Ross A; Vazquez F; Hahn WC; Park PJ; Roberts CWM
Nat Commun; 2019 Apr; 10(1):1881. PubMed ID: 31015438
[TBL] [Abstract][Full Text] [Related]
7. SWI/SNF Chromatin-remodeling Complex Status in SMARCB1/INI1-preserved Epithelioid Sarcoma.
Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Taguchi T; Iwamoto Y; Oda Y
Am J Surg Pathol; 2018 Mar; 42(3):312-318. PubMed ID: 29309303
[TBL] [Abstract][Full Text] [Related]
8. [SMARCA4-deficient thoracic tumors: A new entity].
Decroix E; Leroy K; Wislez M; Fournel L; Alifano M; Damotte D; Mansuet-Lupo A
Bull Cancer; 2020 Jan; 107(1):41-47. PubMed ID: 31916995
[TBL] [Abstract][Full Text] [Related]
9. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.
Watanabe R; Ui A; Kanno S; Ogiwara H; Nagase T; Kohno T; Yasui A
Cancer Res; 2014 May; 74(9):2465-75. PubMed ID: 24788099
[TBL] [Abstract][Full Text] [Related]
10. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer.
Wijdeven RH; Pang B; van der Zanden SY; Qiao X; Blomen V; Hoogstraat M; Lips EH; Janssen L; Wessels L; Brummelkamp TR; Neefjes J
Cancer Res; 2015 Oct; 75(19):4176-87. PubMed ID: 26260527
[TBL] [Abstract][Full Text] [Related]
12. BAFfling pathologies: Alterations of BAF complexes in cancer.
Arnaud O; Le Loarer F; Tirode F
Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
[TBL] [Abstract][Full Text] [Related]
13. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes.
Doan DN; Veal TM; Yan Z; Wang W; Jones SN; Imbalzano AN
Oncogene; 2004 Apr; 23(19):3462-73. PubMed ID: 14990991
[TBL] [Abstract][Full Text] [Related]
14. [Chromatin remodeling defects and cancer: the SWI/SNF example].
Bourdeaut F; Bièche I
Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
[TBL] [Abstract][Full Text] [Related]
15. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
[TBL] [Abstract][Full Text] [Related]
16. Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis.
Zhong R; Liu L; Tian Y; Wang Y; Tian J; Zhu BB; Chen W; Qian JM; Zou L; Xiao M; Shen N; Yang H; Lou J; Qiu Q; Ke JT; Lu XH; Wang ZL; Song W; Zhang T; Li H; Wang L; Miao XP
Sci Rep; 2014 Feb; 4():4147. PubMed ID: 24556940
[TBL] [Abstract][Full Text] [Related]
17. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex.
Sen P; Luo J; Hada A; Hailu SG; Dechassa ML; Persinger J; Brahma S; Paul S; Ranish J; Bartholomew B
Cell Rep; 2017 Feb; 18(9):2135-2147. PubMed ID: 28249160
[TBL] [Abstract][Full Text] [Related]
18. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
[TBL] [Abstract][Full Text] [Related]
19. The SWI/SNF Complex Protein Snr1 Is a Tumor Suppressor in
Xie G; Chen H; Jia D; Shu Z; Palmer WH; Huang YC; Zeng X; Hou SX; Jiao R; Deng WM
Cancer Res; 2017 Feb; 77(4):862-873. PubMed ID: 27923836
[TBL] [Abstract][Full Text] [Related]
20. SWI/SNF chromatin remodeling and human malignancies.
Masliah-Planchon J; Bièche I; Guinebretière JM; Bourdeaut F; Delattre O
Annu Rev Pathol; 2015; 10():145-71. PubMed ID: 25387058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
